Status:
COMPLETED
Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors
Lead Sponsor:
Poitiers University Hospital
Conditions:
Chemeotherapy
Immunotherapy
Eligibility:
All Genders
18+ years
Brief Summary
To limit Corona virus dissemination on its territory, France applied strict confinement from March 16th to May 11th. Scientific societies recommended treatment modifications and remote consultations t...
Eligibility Criteria
Inclusion
- Histologically proven digestive tumor
- Ongoing treatment from March,1st and April 30th
Exclusion
- Patient refusal for enrollment in the study
- Patient not recognised legally competent
Key Trial Info
Start Date :
May 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2020
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04389684
Start Date
May 27 2020
End Date
November 20 2020
Last Update
November 29 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
MOULIN Valérie
La Rochelle, France
2
BOURGEOIS Hugues
Le Mans, France
3
RANDRIAN Violaine
Poitiers, France